Clinical Trials

We are conducting early safety and efficacy trials for vaccines, as well as treatment options and observational studies in the field of infectiology.

Ongoing Trials

  • MVA-MERS-S-Phase 1 Vaccine Trial (4)
  • SARS-CoV-2-ST Vaccine Trial (5)
  • INFLIXCOVID (UK Jena) (6)
  • COVID-19 Studies at the UKE
  • Nationales Pandemie Kohorten Netz des Netzwerk Universitätsmedizin
  • In cooperation with the Bernhardt Nocht Center for Clinical Trails ( BNCCT )
  • Pfizer/ Biontech : A Phase 1/2/3, Placebo-Controlled, Randomized, Observer-Blind, Dose-Finding Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Individuals
  • Pfizer/ Biontech : A Phase 2b, Open-Label Study to Evaluate Safety, Tolerability & Immunogenicity of BNT162b2 in Immunocompromised Participants ≥2 Years

 

More information on UKE - Infektionsforschung und Impfstoffentwicklung

Department for Clinical Immunology of Infectious Diseases

An expierienced researcher looking friendly at the camera
Head of Department

Prof. Dr. Marylyn M. Addo

Telefon: +49 40 285380-42

E-Mail: addo@bnitm.de

  • Logo DZIF